Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05721001 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

French Registry Conducted on E-vita OPEN NEO

Study acronym: NEO
StatusActive, Not Recruiting
PhaseNot specified
SponsorJOTEC GmbH
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
    • Enrollment target: estimated 120 to confirmed 130
    • Study sites: 20 to 23
    • Primary completion date changed from estimate of Mar 31, 2024 to Mar 15, 2024
    • Study completion date: Dec 31, 2027 to Aug 31, 2027
  2. Study sites: 2 to 20v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
JOTEC GmbH
14 trials monitored
See 1 trial at risk
Observational, prospective/retrospective, non-randomised, non-comparative, multicentre cohort study. Primary objective is evaluation of in-hospital all-cause mortality after treatment of extensive acute and chronic aortic pathologies with E-vita OPEN NEO.
Trial Details
NCT Number NCT05721001
Lead Sponsor JOTEC GmbH
Collaborators: ICON plc
Conditions
(from sponsor)		 Vascular Aneurysm
Related terms Aneurysm
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov